Actively Recruiting
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome
Led by Malcom Randall VA Medical Center · Updated on 2025-09-23
24
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.
CONDITIONS
Official Title
Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18-89 years of age
- Required admission to either medical or surgical ICU
- Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days
- Anticipated discharge to home after hospitalization
- Consent from patients themselves or a legally authorized representative if necessary
You will not qualify if you...
- Pregnancy
- Incarceration/Imprisonment
- Life expectancy less than 6 months or enrolled in hospice/palliative care
- Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long term care facility
- Unable to participate in telehealth
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Malcom Randall Veterans Affairs Medical Center
Gainesville, Florida, United States, 32608
Actively Recruiting
Research Team
A
Andrew J Franck, Pharm.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here